background
sinc
august
increas
infect
caus
enteroviru
report
usa
canada
part
children
present
sever
respiratori
symptom
object
determin
whether
increas
sever
respiratori
infect
observ
region
studi
design
sampl
patient
respiratori
symptom
screen
viral
pathogen
includ
rhinoviru
enteroviru
subsequ
sampl
posit
rhinoviru
enteroviru
routin
sequenc
phylogenet
analysi
furthermor
addit
method
use
detect
specif
result
first
three
quarter
year
respiratori
sampl
analyz
test
posit
enteroviru
eighteen
sampl
test
posit
obtain
differ
patient
admit
hospit
eleven
children
age
five
children
need
intens
care
treatment
remain
five
sampl
adult
underli
diseas
three
transplant
patient
heart
lung
renal
transplant
two
underli
lung
condit
copd
asthma
phylogenet
analysi
show
close
relationship
strain
circul
current
usa
belong
known
genet
subtyp
conclus
observ
increas
infect
popul
children
well
adult
case
far
compar
none
singl
case
phylogenet
analysi
identifi
two
similar
cluster
shown
usa
canada
sinc
august
increas
infect
caus
enteroviru
report
usa
canada
outbreak
major
sampl
analyz
children
sever
respiratori
ill
mani
symptom
wheez
also
fatal
document
year
hospit
northern
part
netherland
confront
increas
respiratori
ill
seen
tertiari
care
hospit
also
region
outbreak
shown
caus
increas
incid
respiratori
infect
detect
routin
respiratori
panel
time
ad
enteroviru
pcr
routin
screen
panel
respiratori
virus
influenza
influenza
b
parainfluenzaviru
coronavirus
adenoviru
bocaviru
rsva
rsvb
human
metapneumoviru
moreov
expand
test
routin
sequenc
enteroviru
rhinoviru
strain
identifi
viru
strain
chart
outbreak
transmiss
pattern
ad
sequenc
strategi
includ
norovirus
well
parechovirus
nation
structur
call
typen
avail
dutch
nation
institut
health
rivm
furthermor
use
region
sequenc
epidemiolog
strategi
call
regiotyp
abl
speed
flow
inform
region
includ
hospit
public
health
servic
cover
dens
popul
northern
part
netherland
aim
regiotyp
strategi
provid
rapid
sequenc
http
author
publish
elsevi
bv
open
access
articl
cc
byncnd
licens
http
servic
whole
region
complet
diagnost
sequenc
data
clinic
data
fed
back
databas
creat
sourc
inform
serv
obtain
insight
epidemiolog
pattern
recent
european
center
diseas
prevent
control
ecdc
conclud
rapid
risk
assess
epidem
cluster
sever
diseas
caus
eueea
countri
observ
moder
risk
expect
ecdc
rapid
risk
assess
attribut
low
level
report
low
number
laboratori
routin
screen
respiratori
sampl
subsequ
small
number
case
observ
netherland
enteroviru
peak
season
enterosurveil
iliari
surveil
network
howev
observ
increas
infect
caus
tertiari
care
hospit
sinc
may
similar
outbreak
usa
canada
improv
specif
diagnost
develop
specif
realtim
pcr
method
determin
circul
region
time
outbreak
viru
ongo
north
america
develop
specif
pcr
method
sampl
patient
respiratori
symptom
routin
screen
sever
virus
includ
influenza
b
rsv
type
b
metapneumoviru
parainfluenzaviru
type
coronaviru
adenoviru
bocaviru
rhinoviru
enteroviru
first
three
quarter
year
respiratori
sampl
analyz
sampl
test
posit
enteroviru
select
sequenc
primari
patient
materi
sent
laboratori
analysi
respiratori
virus
routin
screen
rhinoviru
enteroviru
laboratori
develop
realtim
pcr
amplifi
bp
fragment
ntr
region
rhinoviru
enteroviru
differenti
virus
done
use
highli
specif
probe
contain
lock
nucleic
acid
lna
terminu
tabl
rna
extract
l
sampl
addit
l
intern
control
phocin
distemp
viru
pdv
use
nuclisens
easymag
lyon
franc
pcr
perform
total
reaction
volum
l
use
l
rna
fast
viru
master
mix
appli
biosystem
foster
citi
ca
usa
nm
forward
revers
primer
rhinovirusenteroviru
nm
rhinoviru
probe
nm
enteroviru
probe
nm
forward
revers
primer
pdv
nm
probe
pdv
dnasernas
free
water
sigma
reaction
run
use
profil
min
c
c
follow
cycl
c
c
rhinoviru
enteroviru
posit
sampl
routin
type
sequenc
identif
rhinoviru
strain
done
amplif
sequenc
nucleotid
fragment
span
hyper
variabl
part
ntr
entir
gene
terminu
gene
primer
describ
savolainen
et
al
identif
enteroviru
strain
done
amplif
sequenc
basepair
part
gene
describ
nix
et
al
autom
dna
sequenc
use
abi
sequenc
data
analyz
sequenc
analysi
version
abi
subsequ
phylogenet
analysi
perform
use
bionumer
softwar
appli
math
sintmartenslatem
belgium
support
initi
rapid
specif
detect
realtim
pcr
develop
fast
detect
primer
probe
develop
use
align
current
avail
non
code
region
ncr
sequenc
ncbi
databas
primer
express
softwar
appli
biosystem
twentytwo
sampl
span
period
previous
detect
rtpcr
identifi
sequenc
test
valid
determin
specif
six
current
circul
human
rhinoviru
hrv
strain
genogroup
b
c
sampl
contain
differ
enteroviru
speci
includ
test
well
five
refer
strain
provid
dutch
nation
institut
health
refer
fermon
strain
sampl
type
includ
sputum
nasopharynx
flock
swab
stool
cerebrospin
fluid
rna
extract
describ
previous
pcr
perform
total
reaction
volum
l
use
l
rna
fast
viru
master
mix
appli
biosystem
foster
citi
ca
usa
nm
forward
revers
primer
nm
probe
tabl
dnasernas
free
water
sigma
reaction
run
follow
min
c
c
follow
cycl
c
c
c
sinc
begin
respiratori
sampl
test
posit
enteroviru
eighteen
sampl
test
posit
obtain
differ
patient
admit
hospit
tabl
eleven
case
children
five
present
sever
respiratori
ill
requir
intub
mechan
ventil
five
sever
ill
children
two
age
year
month
previous
healthi
two
exprematur
age
month
month
one
previous
healthi
children
patient
given
resuscit
prior
admiss
pediatr
intens
care
unit
one
child
sickl
cell
anemia
underli
condit
month
two
children
admit
moder
sever
bronchiolitistyp
respiratori
infect
wheez
short
breath
four
children
mild
respiratori
infect
common
coldsymptom
children
underli
condit
admit
hospit
interestingli
two
children
patient
acquir
infect
sever
day
admiss
sequenc
isol
ident
sequenc
patient
genbank
access
number
patient
admit
pediatr
intens
care
unit
period
admiss
patient
suggest
nosocomi
transmiss
five
case
infect
adult
adult
patient
underli
condit
predispos
respiratori
tract
infect
one
patient
heart
transplant
patient
one
lung
transplant
patient
one
kidney
transplant
patient
one
asthma
one
chronic
obstruct
pulmonari
diseas
copd
five
adult
admit
hospit
symptom
cough
short
breath
wheez
patient
kidney
transplant
patient
radiolog
sign
compat
pneumonia
case
diagnosi
infect
made
follow
posit
pcr
result
enteroviru
subsequ
sequenc
partial
sequenc
submit
genbank
access
number
test
respiratori
sampl
laboratori
first
three
quarter
sampl
test
posit
enteroviru
differ
enteroviru
type
isol
sampl
tabl
test
highli
specif
strain
test
neg
type
describ
section
assay
design
ncr
clinic
sampl
test
posit
standard
ev
assay
subsequ
type
also
test
posit
specif
pcr
tabl
enterovirus
detect
respiratori
sampl
umcg
number
sampl
total
nd
defin
phylogenet
analysi
show
sequenc
correspond
clade
sequenc
clade
b
describ
tokarz
et
al
none
sequenc
correspond
clade
c
usa
strain
correspond
clade
clade
b
suggest
similar
strain
current
circul
usa
europ
fig
paper
present
case
respiratori
infect
northern
part
netherland
patient
case
admit
hospit
seriou
respiratori
ill
case
five
children
lifethreaten
respiratori
ill
also
note
five
infect
adult
underli
condit
predispos
sever
respiratori
ill
three
transplant
patient
two
pulmonari
condit
five
adult
requir
hospit
care
respiratori
infect
upsurg
respiratori
infect
caus
similar
seen
hospit
importantli
upsurg
hospit
occur
time
period
larg
outbreak
took
place
usa
canada
involv
around
thousand
children
also
usa
children
admit
hospit
test
report
expect
number
north
america
could
higher
adult
popul
sever
respiratori
ill
includ
incid
observ
hospit
locat
least
dens
popul
part
netherland
contrast
low
number
report
infect
rest
netherland
data
known
current
situat
europ
seem
unlik
caus
problem
usa
canada
northern
part
netherland
without
affect
european
region
upsurg
number
children
becam
sever
ill
moreov
shown
case
hospit
acquir
highlight
need
test
patient
sever
respiratori
diseas
also
patient
mild
symptom
may
spread
viru
similarli
current
studi
possibl
wit
inhospit
transmiss
one
sever
ill
child
two
children
develop
mild
respiratori
symptom
low
number
report
infect
europ
may
caus
overal
low
circul
howev
could
also
caus
underdiagnosi
infect
due
insuffici
sampl
patient
respiratori
ill
insuffici
detect
viru
routin
screen
panel
whether
use
laboratori
develop
test
ldt
commerci
assay
qcmd
qualiti
assur
data
known
respiratori
viru
test
perform
number
laboratori
fail
detect
dr
paul
wallac
person
commun
qcmd
glasgow
unit
kingdom
recent
ecdc
report
claim
circul
europ
low
thu
view
context
near
absent
detect
pathogen
addit
potenti
undersampl
consid
although
exact
data
exist
underdiagnos
yet
experi
clinician
least
netherland
discourag
perform
diagnost
test
patient
present
probabl
viral
ill
financi
constraint
test
done
influenza
viru
rsv
prefer
test
recent
initi
european
societi
clinic
virolog
escv
collabor
ecdc
start
investig
preval
europ
epidemiolog
inform
need
larger
scale
current
avail
determin
circul
viru
implicit
risk
focus
limit
number
virus
diagnost
purpos
perform
virolog
diagnost
contest
patient
underli
diseas
whether
children
transplant
patient
patient
chronic
respiratori
condit
get
optim
care
diagnost
option
limit
even
absent
therefor
diagnost
stewardship
program
discuss
asid
antimicrobi
stewardship
infect
control
program
current
introduc
mani
hospit
document
upsurg
associ
sometim
sever
morbid
twice
last
year
ie
anticip
viru
reappear
regularli
therefor
diagnost
assay
whether
ldt
commerci
assay
abl
detect
viru
specif
assay
describ
paper
may
use
purpos
case
describ
paper
diagnos
infect
follow
routin
protocol
laboratori
respiratori
sampl
test
enteroviru
along
respiratori
target
enteroviru
isol
routin
sequenc
sequenc
data
compar
usa
sequenc
data
suggest
similar
strain
circul
usa
europ
conclus
follow
routin
protocol
screen
respiratori
sampl
enteroviru
sequenc
identifi
caus
respiratori
infect
hospit
also
abl
show
potenti
link
ongo
northamerica
associ
time
sever
respiratori
ill
adequ
surveil
virus
like
caus
sever
respiratori
ill
therefor
desir
univers
medic
center
refer
center
collabor
approach
effort
diagnost
refer
laboratori
could
taken
achiev
specif
assay
present
paper
may
aid
assess
real
preval
viru
popul
children
adult
fund
receiv
studi
